Patents Assigned to United States of America as Represented by the Secretary, DHHS Office of Technology Transfer, National Institutes of Health
  • Patent number: 7547712
    Abstract: The present invention relates methods for reducing the adverse effects of nicotine. This application describes the use of nicotine carrier conjugates in decreasing the toxic effects of nicotine on a fetus.
    Type: Grant
    Filed: February 26, 2007
    Date of Patent: June 16, 2009
    Assignees: Nabi Biopharmaceuticals, United States of America as Represented by the Secretary, DHHS Office of Technology Transfer, National Institutes of Health
    Inventors: Sofiane Ennifar, Scott Winston, James Terrill, Steve Fuller